Browsing by Author "Rutkowski, Stefan"

Now showing items 1-2 of 2

    • Thumbnail

      Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification 

      Goddard, Jack; Castle, Jemma; Southworth, Emily; Fletcher, Anya; Crosier, Stephen; Martín Guerrero, Idoia; García Ariza, Miguel; Navajas Gutiérrez, Aurora; Masliah-Planchon, Julien; Bourdeaut, Franck; Dufour, Christelle; Ayrault, Olivier; Goschzik, Tobias; Pietsch, Torsten; Sill, Martin; Pfister, Stefan M; Rutkowski, Stefan; Richardson, Stacey; Hill, Rebecca M; Williamson, Daniel; Bailey, Simon; Schwalbe, Edward C; Clifford, Steven; Hicks, Debbie (Springer, 2023-05)
      Group 4 tumours (MBGrp4) represent the majority of non-WNT/non-SHH medulloblastomas. Their clinical course is poorly predicted by current risk-factors. MBGrp4 molecular substructures have been identified (e.g. subgroups/ ...
    • Thumbnail

      Relapse patterns and outcome after relapse in standard risk medulloblastoma: a report from the HIT-SIOP-PNET4 study 

      Sabel, Magnus; Fleischhack, Gudrun; Tippelt, Stephan; Gustafsson, Göran; Doz, François; Kortmann, Rolf; Massimino, Maura; Navajas Gutiérrez, Aurora; Von Hoff, Katja; Rutkowski, Stefan; Warmuth-Metz, Monika; Clifford, Steven C.; Pietsch, Torsten; Pizer, Barry; Lannering, Birgitta; SIOP-E Brain Tumour Group (Springer, 2016-09)
      The HIT-SIOP-PNET4 randomised trial for standard risk medulloblastoma (MB) (2001-2006) included 338 patients and compared hyperfractionated and conventional radiotherapy. We here report the long-term outcome after a median ...